Abstract
The purpose of this study was to examine the outcome of attempted radical surgical resection in patients with stage IV neuroblastoma. Between 1989 and 2003, 20 (median age 2.4 years, range 0.5–8.7 years) children with stage IV neuroblastoma were treated at the Department of Pediatrics. Surgery was performed in 7 consecutive children (6 male and 1 female) between July 1997 and February 2002 at the Department of Urology in Bonn. Mean age at diagnosis was 57 months (21–104 months). Mean age at the time of surgery was 54 months (8–390 months). Follow-up was available for all patients (100%) and mean follow-up after the operation was 32.5 months (4–56 months). Primary localization of the tumor was retroperitoneal in all cases; 4 out of 7 patients (57%) also had additional adrenal, 3 out of 7 (42%) paraganglion and 1 out of 7 (14%) thoracic primaries. Bone marrow and lymph node metastases were found in all patients (100%). Surgery led to complete tumor resection in 6 out of 7 patients (85%). Surgical approach was abdominal (chevron incision) in 6 out of 7 (85%) of the patients, in one patient the approach was thoraco-abdominal. After induction chemotherapy and delayed surgery, 6 out of 7 (86%) patients showed a complete remission (CR) and the mean CR lasted for about 27.7 months (range 3.1–55.4 months). At the last time of follow-up 5 out of 7 (71%) patients were alive, 2 had died due to recurrent disease. Mean time to recurrent disease was 24 and 51 months, respectively. Mean overall survival time since diagnosis was 38.3 months (11–64 months) and mean event-free survival was 34.5 months (11–60.3 months). The final outcome, overall survival and event-free survival time was influenced by metastatic or local relapse. Tumor resection is beneficial but the value of surgery can only be judged when we are able to control metastatic disease in stage IV neuroblastoma. The final outcome may rely on the extent of complete surgical resection, but is also related to treatment of metastases. A longer follow-up period is indicated to detect long term outcome.
Similar content being viewed by others
References
Berthold F, Utsch S, Holschneider AM (1989) The impact of preoperative chemotherapy on resectability of primary tumour and complication rate in metastatic neuroblastoma. Z Kinderchir 44:21–24
Berthold F, Sahin K, Hero B et al. (1997) The current contribution of molecular factors to risk estimation in neuroblastoma patients. Eur J Cancer 33:2092–2097
Black CT, Haase GM, Azizkham RG et al. (1996) Optimal timing of primary resection in high risk neuroblastoma. Med Pediatr Oncol 27:220–227
Bowman LC, Castleberry RP, Cantor A et al. (1997). Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study. J Natl Cancer Inst 89:373–380
Brodeur GM, Pritchard J, Berthold F et al. (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, staging and response to treatment. J Clin Oncol 11:1466–1477
Canete A, Jovani C, Lopez A et al. (1998) Surgical treatment of neuroblastoma: complications during 15 years experience. J Pediatr Surg 33:1526–1530
Castel V, Tovar JA; Costa E et al. (2002) The role of surgery in stage IV neuroblastoma. J Pediatr Surg 37:1574–1578
Castleberry RP (1997). Paediatric update: neuroblastoma. Eur J Cancer 33:1430–1438
Garaventa A, Boni L, Lo Piccolo MS et al.: Italian Cooperative Group for Neuroblastoma (2002) Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors. Ann Oncol 13:956–964
Haase GM, O’Leary MC, Ramsay NK, Romansky SG, Stram DO, Seeger RC, Hammond GD (1991) Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma. J Pediatr Surg 26:1119–1124
Hase T, Ohta S, Tani T et al. (2002) Outcome of infants with neuroblastoma detected by mass screenig and surgically treated in Shiga Prefecture, Japan: what is the role of surgery? Pediatr Surg Int 18:289–294
Hayes FA, Smith EI (1993) Neuroblastoma. In: Pizzo AP, Poplack GP (eds) Principles and practise of pediatric oncology, 2nd edn. Lippincroft, London, pp 607–622
Hero B, Berthold F (2002) Neuroblastom. Monatsschr Kinderheilkd 150:775–788
Hero B, Kremens B, Klingebiel T, Bender Götze C, Burdach S, Schrappe M, Berthold F (1997) Does megatherapy contribute to survival in metastatic meuroblastoma? A retrospective analysis. Klin Padiatr 209:196–200
Kaatsch P, Haaf G, Michaelis J (1995) Childhood malignancies in Germany—Methods and results of a nationwide registry. Eur J Cancer 31:993–999
Kaneko M, Ohakawa H, Iwakawa M (1997). Is extensive surgery required for treatment of advanced neuroblastoma? J Pediatr Surg 32:1616–1619
Kaneko M, TsuchidaY, Uchino J et al. (1999) Treatment results of advanced neuroblastoma with the first Japanese study group protocol. Study Group of Japan for Treatment of Advanced Neuroblastoma. J Pediatr Hematol Oncol 21:190–197
Kiely EM (1994) The surgical challenge of neuroblastoma. J Pediatr Surg 29:128–133
La Quaglia MP, Kushner BH, Heller G, Bonilla MA, Lindsey KC, Chemy NK (1994) Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome. J Pediatr Surg 29: 1162–1164
Losty P, Quinn F, Breatnach F, O’Meara A, Fitzgerald RJ (1993) Neuroblastoma—A surgical perspective. Eur J Surg Oncol 19:33–36
Matthay KK, Perez C, Seeger RC et al. (1998) Successful treatment of stage III neuroblastoma based on prospective biological staging: a Children’s Cancer group study. J Clin Oncol 16:1256–1264
Matthay KK, Villablanca JG, Seeger RC et al. (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation and 13-cis-retinoic acid. Children’s Cancer Group. N Engl J Med 341:1165–1173
Schilling FH, Spix C, Berthold F, Erttmann R, Klein G, Sander J, Treuner J (2002) Modellprojekt Neuroblastom-Früherkennung. Monatsschr Kinderheilkd 150:934–941
Schilling FH, Spix C, Berthold F et al. (2003) Neuroblastom-Früherkennung im Alter von einem Jahr in Deutschland. Dtsch Arztebl 100:A1739–1746
Schweinitz D von, Hero B, Berthold F (2002). The impact of surgical radicality on outcome in childhood neuroblastoma. Eur J Pediatr Surg 12:402–409
Shamberger RC, Allarde-Segundo A, Kozakewich HP, Grier HE (1991) Surgical management of stages III and IV neuroblastoma: resection before or after chemotherapy? J Pediatr Surg 26:1113–1118
Shamberger RC, Smith EI, Joshi VV, Rao PV, Hayes FA, Bowman LC, Castleberry RP (1998) The risk of nephrectomy during local control in abdominal neuroblastoma. J Pediatr Surg 33:161–164
Sitarz A, Finklestein J, Grosfeld J et al. (1983) An evaluation of role of surgery in disseminated neuroblastoma: A report from the Childrens Cancer Study Group. J Pediatr Surg 18:147–151
Valteau-Couanet D, Rey A, Berthold F (2000). Children over one year of age with stage 4 neuroblastoma: results of the retrospective European study. Med Pediatr Oncol 35:255–263
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bastian, P.J., Fleischhack, G., Zimmermann, M. et al. The role of complete surgical resection in stage IV neuroblastoma. World J Urol 22, 257–260 (2004). https://doi.org/10.1007/s00345-004-0442-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-004-0442-8